Business Unit Head, Rare Metabolic Diseases and Rare Haematology, Takeda
Margaret is the Business Unit Head for Rare Metabolic Diseases and Rare Haematology for Takeda in Ireland, having previously held Franchise Head positions in Genetic Diseases, Internal Medicine and Neuroscience in Shire Pharmaceuticals.
Margaret has over twenty years experience in the pharmaceutical industry, joining Takeda in 2019 through the acquisition of Shire Pharmaceuticals. She has worked in the UK and Ireland in a variety of roles and has experience in sales, learning & development, brand management and team leadership.
Margaret has an active role as the current President in the Pharmaceutical Managers Insitute of Ireland, a vibrant institute with almost 400 members representing over 80 pharmaceutical & industry-related companies in Ireland. The PMI aims to provide its members with opportunities to learn, to connect and collaborate with healthcare sector stakeholders and to grow professionally.